Protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with Vemurafenib in combination with chromatin-targeting compounds (immunofluorescence dataset 3 of 4) - Dataset (ID:20276)
- Detail
- Small Molecules Studied
- Cell Lines Studied
- Proteins Studied
- Antibodies Studied
- Data Columns
- Results
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10317-1 | AGK2 | LSM-43196 | 1183107 | ||
10145-1 | Veliparib | ABT-888 | LSM-1146 | 11960529 | |
10324-1 | Daminozide | LSM-6329 | 15331 | ||
10308-1 | Anacardic acid | LSM-6320 | 167551 | ||
10326-1 | Tranylcypromine | 2-PCPA | LSM-5578 | 19493 | |
10144-2 | Olaparib | AZD2281; KU-0059436 | LSM-1145 | 23725625 | |
10319-1 | BIX-01294 | LSM-4571 | 25150857 | ||
10339-1 | CX-5461 | LSM-6342 | 25257557 | ||
10306-1 | C646 | LSM-43281 | 2871948 | ||
10305-1 | JW55 | LSM-6318 | 2946601 | ||
10311-1 | Entinostat | MS-275; MS-27-275 | LSM-4811 | 4261 | |
10068-1 | Vemurafenib | PLX4032; RG7204; R7204; RO5185426 | LSM-1068 | 42611257 | |
10318-1 | Resveratrol | LSM-42917 | 445154 | ||
10301-1 | Decitabine | 5-aza-2'-deoxycytidine; Dacogen; DAC | LSM-5855 | 451668 | |
10320-1 | UNC0638 | LSM-6325 | 46224516 | ||
10328-1 | (+)-JQ1 | (S)-JQ1 | LSM-6332 | 46907787 | |
10333-1 | UNC669 | LSM-6337 | 46931242 | ||
10330-1 | I-BET | GSK 525762A | LSM-6334 | 46943432 | |
10329-1 | (-)-JQ1 | LSM-6333 | 49871818 | ||
10331-1 | I-BET151 | GSK1210151A | LSM-6335 | 52912189 | |
10282-2 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 | 5311 | |
10315-1 | Rocilinostat | ACY-1215 | LSM-6324 | 53340666 | |
10310-1 | Belinostat | PXD101 | LSM-43181 | 53437714 | |
10335-1 | IOX2 | LSM-6339 | 54685215 | ||
10313-1 | Pracinostat | SB939 | LSM-43290 | 56603532 |